Maryam Lustberg
Maryam Lustberg/LinkedIn

Maryam Lustberg: From Phase 2 Promise to Phase 3 Proof in Neuropathy Prevention

Maryam Lustberg, Director of Breast Center/Chief Breast Oncology at Yale University School of Medicine, shared a post by Nicole Casasanta, Clinical Fellow, Medical Oncology at Yale New Haven Hospital, on X, adding:

“Cooling and compression showing promise in phase 2 studies for taxanes. The definitive phase 3 study is ongoing.”

Maryam Lustberg

Quoting Nicole Casasanta‘s post:

18/21 Tumor Board Tuesday.

Back to our case… Discussed T-DXd + P vs THP HP + AI + OFS + palbo. Shared decision to proceed with THP HP + AI + OFS + palbo.

Currently on THP, Gr 1 neuropathy, limb cooling used for ppx. Are you using limb cooling in your practice?”

More posts featuring Maryam Lustberg and Nicole Casasanta on OncoDaily.